BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

29 related articles for article (PubMed ID: 14192828)

  • 1. Bombay blood group for pediatric cardiac surgery in the era of a pandemic: Newer challenges call for desperate measures!
    Narula J; Saxena R; Bindal S
    Ann Card Anaesth; 2023; 26(3):343-345. PubMed ID: 37470538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibrinogen half-life in children with cyanotic congenital heart disease.
    Thies WR; Göbel U; Liersch R
    Eur J Pediatr; 1982 Sep; 139(1):43-7. PubMed ID: 7173257
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hemostasis and hematocrit - A study on 500 patients with congenital heart disease (author's transl)].
    Schreiber R; Lorenz HP; Bühlmeyer K
    Klin Wochenschr; 1982 Jan; 60(2):61-9. PubMed ID: 7070006
    [No Abstract]   [Full Text] [Related]  

  • 4. Successful pulmonary resection after spontaneous hemopneumothorax in the Eisenmenger syndrome.
    Au J; Cusack SP; Walker WS
    Thorax; 1991 Jul; 46(7):540-1. PubMed ID: 1877044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Excess intravascular coagulation complicating low cardiac output.
    Inglis TC; Breeze GR; Stuart J; Abrams LD; Roberts KD
    J Clin Pathol; 1975 Jan; 28(1):1-7. PubMed ID: 1091659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epsilon aminocaproic acid reduces blood transfusion and improves the coagulation test after pediatric open-heart surgery: a meta-analysis of 5 clinical trials.
    Lu J; Meng H; Meng Z; Sun Y; Pribis JP; Zhu C; Li Q
    Int J Clin Exp Pathol; 2015; 8(7):7978-87. PubMed ID: 26339364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [BLOOD COAGULATION DISORDERS AS A CAUSE OF HEMORRHAGIC COMPLICATIONS IN CONGENITAL HEART DEFECTS].
    PERLICK E
    Z Gesamte Inn Med; 1964 Jul; 19():SUPPL:35-7. PubMed ID: 14230587
    [No Abstract]   [Full Text] [Related]  

  • 8. [CHANGES IN SOME COAGULATION FACTORS IN CONGENITAL CYANOTIC HEART DEFECTS. PRELIMINARY REPORT].
    PROCHAZKA J; VYHNALEK J
    Cesk Pediatr; 1964 Feb; 19():123-9. PubMed ID: 14142683
    [No Abstract]   [Full Text] [Related]  

  • 9. Occult haemorrhagic diathesis in children with congenital heart disease.
    Hooja V; Sanyal SK; Agarwal KN; Dasgupta BN; Ghosh S
    Indian Pediatr; 1969 Nov; 6(11):691-6. PubMed ID: 5375504
    [No Abstract]   [Full Text] [Related]  

  • 10. POST-OPERATIVE HAEMORRHAGE AND RELATED ABNORMALITIES OF BLOOD COAGULATION IN CYANOTIC CONGENITAL HEART DISEASE.
    SOMERVILLE J; MCDONALD L; EDGILL M
    Br Heart J; 1965 May; 27(3):440-8. PubMed ID: 14284363
    [No Abstract]   [Full Text] [Related]  

  • 11. Heparin treatment of haemorrhagic diathesis in cyanotic congenital heart-disease.
    Dennis LH; Stewart JL; Conrad ME
    Lancet; 1967 May; 1(7499):1088-9. PubMed ID: 4164776
    [No Abstract]   [Full Text] [Related]  

  • 12. HEMORRHAGIC DIATHESIS IN PATIENTS WITH CYANOTIC CONGENITAL HEART DISEASE: PREOPERATIVE MANAGEMENT.
    JACKSON DP
    Ann N Y Acad Sci; 1964 Jul; 115():235-51. PubMed ID: 14192828
    [No Abstract]   [Full Text] [Related]  

  • 13. Coagulation abnormalities in patients with cyanotic congenital heart disease.
    Tempe DK; Virmani S
    J Cardiothorac Vasc Anesth; 2002 Dec; 16(6):752-65. PubMed ID: 12486661
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.